InvestorsHub Logo

GreenGenie

11/27/16 1:50 PM

#5276 RE: Alan Brochstein #5275

That's interesting, Alan, because the company doesn't do much talking. Just a lot of doing.

I hope you are right about an interesting week. Could use one. Valuation is high in my opinion, but that's how markets work. They go high; they go low. Opinions and interpretations don't always align with yours.

MassRoots has negative working capital, about 1/3 the sales of HLIX, and about 1/6 the market cap. Would you agree? I think HLIX is at least 6 times more interesting, probably 10 times better managed, and surely offers 10 times the promise. And yet, HLIX does a whole lot less talking and a whole lot more doing.

However, in my *opinion*, both are pretty expensive and definitely not trading at a discount or where I would call a "margin of safety." According to my understanding which is where we agree. Although, I feel confident I'd have a higher valuation than yours. But there is nothing wrong with that. That's why they call it a market. Projections, interpretations, capitalism.

"Alleged" misrepresentations with the two market leaders can't be what you are hearing about since they are both quoted in the few "communications" released from the company.

You can't make the case that Cannabase has misrepresented itself, having a long private history. The only thing foggy is a deal with BioTrack, and there isn't much said about it. We shall see, but I have a hunch that you have personal problems to overcome. One, learning how to be wrong gracefully; and two, learning that you had HLIX wrong and jumped to too many conclusions.

GreenGenie

11/27/16 2:27 PM

#5277 RE: Alan Brochstein #5275

Good Press

ALTHOUGH, they have made some comparisons to the "market leaders" and offered a better interpretation as to why their "competitors" who "are not real competitors" are doing so lousy.

IFFF it is a competitor that comes out with some mud slinging, making a libel claim, that would be good and free press. Helix TCS could defend itself and expand on why they are lousy competitors. I have listened to all communications, and I'm confident any libel claims could be easily defended.

So I HOPE that is what you heard about. We shall see! As BBRY's turnaround CEO Chen said, "any press is good press!"

GreenGenie

11/27/16 4:45 PM

#5280 RE: Alan Brochstein #5275

Mark to Market

Alan, would you like to show off and explain the "Mark to Market" write down and how you believe it relates to HLIX in their latest quarterly filing? I know what it is, but I don't understand its application here.

GreenGenie

11/29/16 12:39 PM

#5281 RE: Alan Brochstein #5275

The Moral was HOLD and Don't Sell

So far, Alan, all I hear are crickets. Par for the course.

So far, even though I was right and you were wrong, I'm still only half right. Too much action and too much thinking is proving to be a futile exercise so far.

Had I never sold a single share of HLIX, my 10,000 shares would be equal to what I ended up selling for right now as we speak. I also wouldn't be facing any capital gains. The stock needs to drop another 15% to be a true break-even for my safety maneuvers.

The real riddle here, however, is why did you pass on this great opportunity when I brought it to you on a silver platter?

I have two more cards up my sleeve. One is face up and one is face down. If you want to learn about my knack for an empty shell, one of those cards is face up. IFF you are ready to do some learning yourself, that is. It's not luck when you have loaded dice. The loading dice being research, experience, the scientific process, and a little speculation with a heavy dose of savvy extrapolation.

MAGA90210

11/29/16 7:52 PM

#5282 RE: Alan Brochstein #5275

What do you mean

Alan Brochstein

11/29/16 8:34 PM

#5283 RE: Alan Brochstein #5275

I think we will find out Thursday that there are alleged inaccuracies with the public communications lately from HLIX, if that is the question. My guess is that it is this press release:

https://helixtcs.com/press-release/helix-tcs-become-largest-shareholder-biotrackthc/

It wasn't even mentioned in their OTC filing, which was odd. Yet more evidence that one should never believe anything a company says if they don't file with the SEC.

If this guy Venegas is the real deal, it's not clear why he allows himself to look like a penny stock clown with his rapacious preferred stock, his excessive stock promotion and his not filing with the SEC. I haven't yet had time to really dig into his background, but things are slowing down and that is on my to-do list.